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Abstract Diabetes mellitus (DM) is a multifactorial
chronic metabolic disease characterized by hyperglyca-
emia. Several different mechanisms have been implicated
in the development of the disease, including endoplasmic
reticulum (ER) stress. ER stress is increasingly acknowl-
edged as an important mechanism in the development of
DM, not only for b-cell loss but also for insulin resistance.
Accumulating evidence suggests that ER stress-induced
apoptosis may be an important mode of b-cell loss and
therefore important in the development of diabetes. Recent
data also suggest a role of ER stress-induced apoptosis in
liver and adipose tissue in relation to diabetes, but more
extensive studies on human adipocyte and hepatocyte
(patho)physiology and ER stress are needed to identify the
exact interactions between environmental signals, ER
stress and apoptosis in these organs.
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Introduction
Diabetes mellitus (DM) is a multifactorial chronic meta-
bolic disease characterized by hyperglycaemia. Several
different mechanisms have been implicated in the devel-
opment of the disease. Although the precise molecular
events underlying the different forms of diabetes still
remain unclear, it is generally accepted that the underlying
defects include decreased secretion of insulin, its impaired
signalling or both. Type 1 diabetes (T1DM) is known to
result from an excessive loss of pancreatic b-cells, leading
to insulin deﬁciency. Among other important causes,
autoimmune and inﬂammatory processes have been
reported to disrupt b-cells, cause insulin deﬁciency and
hyperglycaemia and subsequently T1DM. Type 2 diabetes
(T2DM), the most common form of diabetes, is charac-
terized by impaired insulin action (insulin resistance) par-
alleled by impaired insulin secretion and a progressive
decline in b-cell function. Insulin resistance, often associ-
ated with obesity and physical inactivity, is a major factor
in the progression of T2DM. Obesity is a well-known risk
factor for the development of T2DM. Importantly, obesity
is not only associated with lipid accumulation in adipose
tissue, but also in non-adipose tissues, such as liver and
muscle. Lipid accumulation in non-adipose tissue, also
known as ectopic lipid accumulation, has also been asso-
ciated with the development of insulin resistance. There-
fore, muscle, adipose tissue and liver are, beside pancreas,
crucial tissues contributing to the development of insulin
resistance and thus to the development of T2DM.
A relatively new player in the DM ﬁeld is endoplasmic
reticulum (ER) stress. ER stress and/or ER stress-induced
apoptosis are increasingly acknowledged as important
mechanisms in the development of DM, not only for b-cell
loss but also for insulin resistance. Since the last decade, it
has been generally accepted that ER stress plays an
important role in b-cell function and loss [1]. This is for
instance illustrated in Akita mice [2, 3], and the Wolcott-
Rallison syndrome [4, 5]. Akita mice spontaneously
develop diabetes with signiﬁcant early loss of pancreatic
b-cell mass resulting from a missense mutation (Cys96Tyr)
in the insulin 2 gene that disrupts a disulﬁde bond between
A and B chains of insulin [6]. The Wolcott-Rallison syn-
drome is a rare autosomal-recessive disorder characterized
by the association of permanent neonatal or early-infancy
insulin-dependent diabetes, and growth retardation, and
other variable multisystemic clinical manifestations. The
gene responsible for this syndrome is EIF2AK3 (PERK),
the pancreatic eukaryotic initiation factor 2 (eIF2) kinase
[4, 5]. More recently, it was acknowledged that high fat-
and obesity-induced insulin resistance is also associated
with ER stress in adipose tissue and liver [7, 8]. Remark-
ably, until now no studies have demonstrated a role for ER
stress in skeletal muscle in relation to (the development of)
obesity or diabetes [7, 9]. Besides, the role of ER stress in
the development of diabetes that will be discussed in this
paper, there is also evidence that diabetes can induce or
aggravate ER stress and thereby affect the complications of
diabetes, such as renal disease, retinopathy and vascular
abnormalities [10–12].
In this review an overview of ER stress, the unfolded
protein response (UPR), and ER stress induced apoptosis is
given (see also refs [13–20]) with a further focus on the
possible role of ER stress-induced apoptosis in the liver
and adipose tissue in the onset of diabetes.
Endoplasmic reticulum stress-unfolded protein
response
The endoplasmic reticulum (ER) is an important organelle
required for cell survival and normal cellular function. In
the ER, nascent proteins are folded with the assistance of
ER chaperones (i.e. molecular chaperones and folding
enzymes). Subsequently, correctly folded proteins are
transported to the Golgi apparatus. Unfolded and misfolded
proteins, on the other hand, are retained in the ER, retro-
translocated to the cytoplasm by the machinery of ER
associated degradation (ERAD), and degraded by the pro-
teasome. As a major intracellular calcium storage com-
partment, the ER also plays a critical role towards
maintenance of cellular calcium homeostasis. In addition,
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123the ER also has a role in lipid biosynthesis, e.g. lipid
membrane synthesis and controlling the synthesis of cho-
lesterol and other membrane lipid components.
ER stress is caused by perturbations of any of the three
homeostatic functions of the ER, i.e. functioning as a site
for protein folding, for synthesis of unsaturated fatty acids
(FA), sterols, and phospholipids and for intracellular Ca
2?
storage. ER stressors include: (1) disturbances in cellular
redox regulation caused by hypoxia, oxidants, or reducing
agents, which interfere with disulﬁde bonding of proteins in
the lumen of the ER, (2) glucose deprivation, probably by
interfering with N-linked protein glycosylation in the ER,
(3) disruption of Ca
2? metabolism causing impaired func-
tions of Ca
2? dependent chaperones such as Grp78, Grp94
and calreticulin, (4) viral infections, which overload the ER
with virus encodedproteins, (5) high fat diet, and (6) protein
mutations that hamper adequate folding [17, 18]. The con-
sequence of ER stress is an overwhelmed or compromised
ability of the ER to properly fold proteins.
Accumulation of unfolded and/or misfolded proteins in
the ER lumen is a hallmark of perturbation of any of the
three functions of the ER and results in activation of the
unfolded protein response (UPR). The UPR is a complex
and coordinated adaptive signalling mechanism to re-estab-
lish homeostasis of ER functions (Fig. 1). ER stress sensors
[IRE1 (inositol requiring 1), ATF6 (activated transcription
factor 6) and PERK (ER-resident PKR-like eIF2a kinase)]
detect the accumulation of unfolded and/or misfolded
protein at the onset of ER stress and initiate the UPR. To
re-establish homeostasis and normal ER function, the UPR
initiates a global decrease in protein synthesis while
increasing the production of ER chaperone proteins and
ER-associated degradation (ERAD).
The mammalian UPR with its signalling components is
complex, diverse and ﬂexible as has been described in great
detail in recent reviews [16, 20]. In short, UPR signals
through three pathways, that each utilizes one of the three
ER stress sensors IRE1, ATF6 and PERK (Fig. 2). IRE1 is a
transmembrane kinase/endoribonuclease (RNAse). Activa-
tion of IRE1 initiates the nonconventional splicing of Xbp-1
mRNA. Spliced Xbp-1 mRNA encodes a transcription
activator that drives transcription of genes such as ER
chaperones, whose products directly participate in ER
protein folding. PERK is a transmembrane kinase that
phosphorylates the eukaryotic translation initiation factor 2
subunit (eIF2). This leads to a reduced protein synthesis,
which counteracts ER protein overload. ATF6 is an
ER-resident transmembrane protein. Upon activation, the
cytoplasmic domain of ATF6 is released from its membrane
anchor by regulated proteolysis. The cleaved N-terminal
fragment migrates to the nucleus, acts as an active tran-
scription factor, and increases the expression of the genes
encoding proteins that function to augment the ER protein
folding capacity. The exact mechanism of UPR activation is
unknown. One of the most described models is the com-
petition model, in which the ER chaperone protein glucose
regulated protein (Grp)78/BiP, is an UPR regulator and
plays an essential role in the activation of IRE1, PERK and
ATF6. In the inactive state, i.e. in resting cells, all three ER
stress sensors (IRE-1, PERK and ATF6) are maintained in
an inactive state through their association with the ER
chaperone BiP (Fig. 2a). When the ER homeostasis is
perturbed, i.e. upon ER stress, BiP is sequestered by
unfolded and/or misfolded proteins that accumulate in the
ER lumen (Fig. 2b, c). Dissociation of BiP from de ER
stress sensors triggers the activation of IRE1, PERK and
ATF-6 (Fig. 2d). Other models of UPR activation are the
ligand-binding model in which unfolded and/or misfolded
proteins directly interact with the ER stress-sensing
domains of the ER stress sensors, and the probing model, in
which newly synthesized stress-sensing proteins probe the
efﬁciency of the ER-resident protein-folding machinery by
presenting themselves as substrates to the folding machin-
ery [20].
Endoplasmic reticulum stress—apoptosis
Under conditions of severe and prolonged ER stress, the
UPR is unable to restore normal cellular function. Subse-
quently, cell death, usually occurring by apoptosis, is trig-
gered (Fig. 1). Cell death results in loss of cell/tissue
function and may be the primary reason for the manifesta-
tionofdiseaseinseveralERstress-relateddisorders.Indeed,
cell death induced by ER stress has been implicated in a
wide variety of diseases including ischemic injury (stroke,
myocardial infarction), heart failure, several neurodegen-
erative diseases, diabetes and bipolar disorder [17, 18]. The
mechanisms of apoptosis are highly complex, involving an
energy-dependent cascade of molecular events. There are
twomainapoptoticpathways:the extrinsicordeathreceptor
Endoplasmic Reticulum Stress
e.g. high glucose, FFA, inflammation
Accumulation of unfolded proteins in the ER
Re-establish homeostasis
Normal ER function
Failure to restore homeostasis 
Cell death, usually apoptosis
Activation of the Unfolded Protein response (UPR)
Fig. 1 The relation between ER stress and ER stress induced
apoptosis in the development of diabetes
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123pathway and the intrinsic or mitochondrial pathway [21].
Current evidence suggests that these two pathways are
linked and that molecules in one pathway can inﬂuence the
other [22]. The extrinsic signalling pathways act via trans-
membrane receptor-mediated interactions. These involve
death receptors that are members of the tumor necrosis
factor (TNF) receptor gene superfamily [23]. The intrinsic
signalling pathways involve a diverse array of non-receptor-
mediated stimuli that produce intracellular signals that act
directly on targets within the cell and are mitochondrial-
initiated events. These non-receptor stimuli include radia-
tion, toxins, hypoxia, hyperthermia, viral infections, and
free radicals but also the absence of certain growth factors,
hormones and cytokines [21].
Signalling through the ER stress sensors can trigger
pro-apoptotic signals during prolonged ER stress. How-
ever, the ER stress sensors do not directly cause cell death
but rather initiate the activation of downstream molecules
such as CHOP or JNK, which further push the cell down
the path of death. This results in caspase activation, the
execution phase of ER stress-induced apoptosis, and
ﬁnally in the ordered and sequential dismantling of the
cell. Caspases are cysteine proteases that exist within the
cell as inactive pro-forms or zymogens and are cleaved to
form active enzymes following the induction of apoptosis.
ER stress activates both intrinsic and extrinsic apoptotic
pathways [13, 14]. Currently, three main pathways of ER
stress-induced apoptosis are identiﬁed (Fig. 3): (1) the
proapoptotic pathway of CHOP/GADD153 transcription
factor which is mainly induced via PERK/eIF2, (2) IRE1-
mediated activation of apoptosis signal-regulating kinase 1
(ASK1)/c-Jun NH2-terminal kinase (JNK), and (3) acti-
vation of the ER localized cysteine protease, caspase 12
[15, 18, 19].
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Fig. 2 The unfolded proteins response and its signaling components.
A simpliﬁed scheme of the initiation of the unfolded protein response
(UPR). In the inactive state, i.e. in resting cells, all three ER stress
sensors (IRE-1, PERK and ATF6) are maintained in an inactive state
through their association with the ER chaperone BiP (a). Upon ER
stress, BiP is recruited by the unfolded and/or misfolded proteins (b).
This results in BiP dissociation from its conformational binding state
to the transmembrane receptor proteins PERK, IRE1 and ATF6 (c).
Dissociation results in activation of IRE1, PERK and ATF6 (d). The
activated cytosolic domain of PERK phosphorylates the eukaryotic
translation initiation factor 2 subunit (eIF2), inhibiting translation.
The activated cytosolic domain of IRE1 initiates the nonconventional
splicing of Xbp-1 mRNA, thereby cleaves a 252 bp intron from
XBP1. Spliced Xbp-1 mRNA encodes a transcription activator that
drives transcription of genes such as ER chaperones, whose products
directly participate in ER protein folding. Activated ATF6 translo-
cates to the Golgi, cleaved by proteases to form an active 50 kDa
fragment. ATF6 p50 and XBP1 bind ER stress-response element
(ERSE) promoters in the nucleus to produce up regulation of the
proteins that function to augment the ER protein folding capacity
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and the development of diabetes
ER stress, UPR and apoptosis in the pancreas
b-cell loss plays a crucial role in the development of insulin
deﬁciency and in the onset and/or progression of diabetes.
Regulation of the b-cell mass involves a balance of b-cell
replication and cell death. Accumulating evidence suggests
that apoptosis may be the main mode of b-cell death in
both types of diabetes. Recent studies point to a role of the
ER in the sensing and transduction of apoptotic signals in
b-cells as recently described in detail in excellent reviews
[19, 24]. We now addressed the most relevant data of the
last year, with a focus on ER stress and apoptosis in the
pancreas, adipose tissue and the liver.
Several studies show evidence for a role of ER stress in
b cell failure. Mutations in the primary sensors of the UPR
or mutations that affect chaperone functions of the UPR,
e.g. EIF2AK3, IRE1, P58
IPK (DNAJC3) and EIF2a, impair
b cell health and function [4, 25–28]. Moreover, mutations
in proinsulin causing disruption of disulﬁde bond pairing
result in misfolding and accumulation of proinsulin in the
ER lumen of b cells. This accumulation can cause b cell
failure [6, 29, 30]. In vivo data show that also pathological
conditions like high glucose, free fatty acids, cytokines,
and nitric oxide induce UPR gene expression and com-
promise b cell function [25, 31–33]. Moreover, in islets of
T2DM patients, ER stress has been demonstrated by
increased staining for ER chaperones and CHOP along
with increased ER size [34–37].
However, the exact molecular mechanisms for the ER
stress-induced apoptosis in b cells are not entirely clear. The
most recent data support that the PERK-ATF4-CHOP stress
signalling pathway is important in b-cell apoptosis (Fig. 3).
This pathway plays a role in b-cell injury induced by oxi-
dative stress and saturated fatty acids [38–42]. This is
conﬁrmed by the ﬁnding that CHOP deletion reduces oxi-
dative stress, improves b cell function, and promotes cell
survival in multiple mouse models of diabetes [39]. How-
ever, the PERK-ATF4-CHOP pathway is not the only
pathway inducing apoptosis in b-cells. In contrast to apop-
tosis by high lipids, the PERK-ATF4-CHOP ER stress–
signalling pathway is not necessary for cytokine-induced
b-cell death [42]. Other data show that also the IRE1-JNK
pathway is associated with the apoptosis in b cells [41]
(Fig. 3). This pathway is also involved in ER stress-induced
apoptosis caused by chronic high glucose, fatty acids, and
Il-1b induced depletion of Ca
2? [41, 43–45].
ER stress, UPR and apoptosis in adipose tissue
The prevalence of obesity is increasing rapidly worldwide,
especially in developing countries. Animportantconsequence
of obesity is an increased risk of developing impaired glucose
tolerance and T2DM. Indeed, along with the increase in
obesity, a parallel increase in the prevalence of T2DM,
impaired glucose tolerance has occurred [46, 47]. The meta-
bolic complications of obesity, usually referred to as the
metabolic syndrome, consist of insulin resistance (often cul-
minating in b-cell failure, impaired glucose tolerance and
T2DM), dyslipidemia, hypertension, and premature heart
disease. Our understanding of the role of adipose tissue in
metabolic syndrome has continued to evolve with the iden-
tiﬁcation of adipose tissue as a potent endocrine organ. Adi-
pose tissue secretes large amounts of adipocyte-generated
factors, such as adipokines, cytokines and complement com-
ponents. Cells that are specialized for a high secretory
capacity, such as mature B lymphocytes, liver cells and
pancreatic b-cells, are known to expand and adopt their ER
capabilities to meet an increased demand of protein synthesis
[48]. It is, therefore, likely that ER stress plays a role in adi-
pose tissue dysfunction and most probably also in cell death.
Although apoptosis of (pre)adipocytes has not been
extensively studied, there is growing evidence that, under
Endoplasmic
PERK
BiP Reticulum
Stress IRE1
TRAF2
ASK1
eiF2α
pro-caspase-12
caspase-12 JNK
ATF4 caspase
cascade
CHOP
= unfolded protein
APOPTOSIS
Endoplasmic Reticulum
Fig. 3 ER stress induced apoptosis. Three main pathways of ER
stress-induced apoptosis are identiﬁed: (1) the proapoptotic pathway
of CHOP/GADD153 transcription factor which is mainly induced via
PERK/eIF2. CHOP down-regulates the anti-apoptotic factor B cell
lymphoma-2 (Bcl-2), but also upregulates Ero-1, a thiol oxidase that
promotes protein folding in the ER but also generates reactive oxygen
species (ROS), and thereby promotes apoptosis, (2) IRE1-mediated
activation of apoptosis signal-regulating kinase 1 (ASK1)/c-Jun NH2-
terminal kinase (JNK). IRE1 interacts with TRAF2 (TNF receptor-
associated factor-2) and ASK1. This leads to activation of ASK1 and
JNK, followed by apoptosis, and (3) activation of the ER localized
cysteine protease, caspase 12. Caspase 12 is activated by m-Calpain
in the cytoplasm. Activation of m-Calpain is a consequence Ca
2?
efﬂux out of the ER upon ER stress. These three pathways all end in
caspase cascade activation, the execution phase of ER stress-induced
apoptosis
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123speciﬁc circumstances, decreases in adipose tissue mass in
humans could result from a loss of fat cells through pro-
grammed cell death. The general idea is that in a normal
healthy situation adipocyte number is relatively stable
when the energy intake is less than the energy output. In
this case, the adipose tissue mass only decreases as a result
hypotrophy via mobilization of triglycerides [49]. On the
other hand, conditions of pathological fat wasting can
involve loss of adipocytes through apoptotic mechanisms.
For example, apoptotic events were observed in fat tissue
of patients with tumor cachexia and in the fat remodelling
processes associated with highly active antiretroviral ther-
apy, e.g. ritonavir, in HIV infected patients with lipodys-
trophy [50–52]. Ritonavir not only induces apoptosis and
inhibits adipocyte differentiation, but also affects inﬂam-
matory mediators, ER stress and oxidative stress, as shown
by gene proﬁling [53, 54].
Recent data suggest that ER stress may, via several
mechanisms, also be involved in apoptosis of (pre)adipo-
cytes in relation to the development of obesity/diabetes. In
obese individuals, adipose tissue is poorly oxygenated [55,
56], which may lead to local hypoxia in adipose tissue. ER
stress may form a link between hypoxia and apoptosis.
Disturbances in cellular redox regulation caused by
hypoxia interfere with disulphide bonding in the lumen of
the ER, leading to unfolded and misfolded proteins. In
3T3-L1 adipocytes, hypoxia is associated with ER stress, as
shown by increased levels of GRP78 and CHOP [57]. Yin
et al. [58] described that hypoxia induces cell death, pro-
motes free FA release and inhibits glucose uptake in adi-
pocytes by inhibition of insulin signalling pathway. These
metabolic effects of hypoxia may also add to the generation
of ER stress, e.g. in addition to hypoxia itself, palmitate, a
saturated fatty acid (FA), also activated UPR and induced
apoptosis in preadipocytes. CHOP was one of the proteins
that were inﬂuenced [59]. Moreover, very recently, three
papers for the ﬁrst time show ER stress in human adipose
tissue [60–62]. Although none of these papers show direct
evidence for a relation between obesity and ER stress-
induced apoptosis, the results of Sharma et al. [61], are
very suggestive for this. They used ATF4, GADD43 and
ATF3 as markers of apoptosis pathways, and show a
relation with obesity. Thus, although the data strongly
suggest a role for ER stress in apoptosis of adipose tissue,
experiments are needed to fully explore this pathway.
For all studies performed with adipose tissue biopsies, it
should be emphasized that the precise identity of cells
within adipose tissue that show ER stress, and possibly
related apoptosis, is not clear. Adipocytes generally
account for only 50% of the total number of cells in adi-
pose tissue. Other cells within adipose tissue, e.g. preadi-
pocytes, macrophages and vascular cells, can also secrete
an extensive range of protein signals and factors linked to
inﬂammatory response and may therefore also be sensitive
for ER stress. This is of special interest since adipose tissue
is more and more recognized as a tissue containing a
molecular network that connects obesity, adipokine secre-
tion, chronic inﬂammation and insulin resistance. Inﬂam-
mation of adipose tissue is often observed in obesity and
diabetes and is associated with the inﬁltration of macro-
phages into adipose tissue, which may be triggered by
adipocyte death, adipokine secretion e.g. TNF-alpha and
IL-6, and elaboration of chemokines by adipocyte e.g.
monocyte chemo-attractant protein (MCP)-1 [63–65]. The
mechanism via which adipocyte death stimulates macro-
phage inﬁltration has been proposed to occur via an alter-
native death pathway that share features of both necrosis
and apoptosis [66]. This possibility is supported by the
ﬁnding that macrophages are located around dead adipo-
cytes in the adipose tissue [67]. Apoptosis of macrophages
in adipose tissue may also be linked to diabetes. It has been
suggested that macrophage cell death in adipose tissue is an
important effect of pioglitazone treatment and this may
play an essential role in the management of diabetes mel-
litus and metabolic syndrome [68]. Hypoxia and hypoxia
related ER stress may also play a role in apoptosis of
macrophages in adipose tissue. Hypoxia does not only
stimulate the inﬂammatory response of macrophages [69,
70], but also induced apoptosis and cell cycle arrest at
G0/G1 phase, via AKT and JNK [71]. To our knowledge
no studies have been published on adipose tissue histology
showing ER stress related apoptosis in a speciﬁc cell type.
ER stress, UPR and apoptosis in the liver
ER stress has been recognized in various models of liver
injury and human liver diseases (as reviewed in [72]). The
liver plays essential roles in metabolism, biosynthesis,
excretion, secretion and detoxiﬁcation. Comparable to
adipose tissue, the liver contains a range of different cell
types. The three main liver cell types are hepatocytes,
resident macrophages (i.e. Kupffer cells), and endothelial
cells. Apoptosis in the liver occurs in many forms of liver
injury, e.g. chronic viral liver disease, nonalcoholic and
alcoholic steatohepatitis [73–76].
Nonalcoholic fatty liver disease (NAFLD) results from
metabolic hepatic dysregulation in metabolic syndrome
and T2DM. NAFLD refers to a wide spectrum of liver
disease ranging from simple fatty liver (steatosis), to
nonalcoholic steatohepatitis (NASH), to cirrhosis (irre-
versible, advanced scarring of the liver). Several studies
have shown that NAFLD predicts future development of
T2DM (reviewed in [77]). The pathogenesis of NAFLD is
thought to be a multiple-hit process involving insulin
resistance, oxidative stress, apoptosis, and adipokines. In
NASH, inﬂammation of the liver is associated with the
Apoptosis (2009) 14:1424–1434 1429
123accumulation of fat in the liver and additionally to different
degrees of scarring, which may lead to severe liver scarring
and cirrhosis. The general idea is that as consequence of
both hepatic and peripheral insulin resistance, the hepato-
cellular accumulation of triglycerides, initially leads to an
altered metabolism of glucose and free fatty acids in the
liver. Increased expression of death receptors in response to
this altered hepatic metabolism enhances the hepatocytes’
susceptibility for pro-apoptotic stimuli, thus eliciting
excessive hepatocyte apoptosis and inﬂammation. Inter-
estingly, hepatocyte apoptosis is signiﬁcantly increased in
patients with NASH and correlates with disease severity
[75, 78].
Evidence is mounting for an important role for ER
stress-induced apoptosis in NAFLD. In relation to the onset
of diabetes, most in vivo and in vitro studies on the relation
between ER stress-induced apoptosis and fatty liver focus
on saturated FA. Saturated FA induce ER stress and
apoptosis at physiologic concentrations and with a rela-
tively rapid time course in H4IIE liver cells [79, 80], as
illustrated by the induction of ER stress response genes and
apoptosis which occurred after 4 h and between 6 and 16 h,
respectively [79]. Ozcan et al. [7] showed that chronic
excessive nutrient intake activated the UPR both in liver
and in adipose tissue. A very recent study used transgenic
mice carrying the XBP-1-delta-DBD-venus expression
gene, which acts as an ER stress-activated indicator
(ERAI). In these transgenic mice, the gene encoding venus,
a variant of green ﬂuorescent protein, is fused as a reporter
downstream of a partial sequence of human XBP-1
including the ER stress-speciﬁc intron. The XBP-1/venus
fusion protein is produced in cells under ER stress condi-
tions, and cells under ER stress can be detected by moni-
toring the generation of ﬂuorescence. They showed in the
liver of the ERAI transgenic mice that ERAI ﬂuorescence
was observed as early as 4 weeks after treatment with a
high fat, high sucrose (HF/HS) diet, whereas it was not
detected in the fat and muscle, even after 12 weeks of
HF/HS diet treatment [9]. It is important to realize that not
all FA activate the UPR. Only livers and hepatocytes from
rats on a high saturated fat diet, but not high polyunsatu-
rated fat diet, were characterized by the presence of spliced
XBP-1 mRNA and increased GRP78 and CHOP protein
[81]. This not only suggests that the UPR may sense and
respond to the fatty acid environment but also that the ratio
of saturated to unsaturated FA may be an important
determinant of hepatic ER homeostasis. Although not
directly shown in hepatocytes, several mechanisms have
been proposed for fatty acid induced ER stress. One pos-
sible mechanism is the rapid incorporation of palmitate into
lipid components of the rough ER followed by disruption
of ER structure and function [82]. Another mechanism of
palmitate-induced ER stress is the generation of reactive
oxygen species (ROS). ROS by itself can induce ER stress.
Prolonged or severe ER stress, which may occur in the
presence of excess palmitate, can lead to further ROS
accumulation, potentially amplifying the apoptotic/cell
death response [83]. Alternatively, as described in b cells,
palmitate
can lead to an early and sustained depletion of ER Ca
2?
stores, which may trigger ER stress via impaired protein
folding [41].
ER stress—UPR—insulin resistance
ER stress and the UPR are not only associated with
apoptosis in of b-cells, hepatocytes and adipocytes but also
with metabolic derangements, especially with insulin
resistance. In adipose tissue and liver, the relation of ER
stress with insulin resistance is actually more evident than
its relation with apoptosis. The general idea is that ER
stress interferes with the signalling of the insulin receptor
via JNK (Fig. 4). Therefore JNK can not only be a link
between ER stress and apoptosis (Fig. 3) but also between
ER stress and insulin resistance. A major site of regulation
of insulin signalling, both positive and negative, is phos-
phorylation of the important insulin receptor docking
protein insulin receptor protein-1 (IRS-1), whereby phos-
phorylation of the tyrosine (Tyr) residues in IRS-1 induces
phosphorylation of the serine (Ser) residues in IRS-1 and
hampers insulin signal transduction (reviewed in [84]).
Although the exact mechanisms that lead to Ser phos-
phorylation of IRS-1 are not yet known, it is apparent that
several intracellular serine kinases, e.g. IjB kinase (IKK)
and JNK, mTOR and PKC-h are involved. A wide variety
of factors, including nutrients such as FA and amino acids,
have been found to induce insulin resistance at least in part
through inhibitory IRS-1 Ser phosphorylation. Insulin
resistant states (e.g obesity, T2DM) are associated with
activation of JNK and/or IKK leading to Ser phosphory-
lation of IRS1 and hence induction of insulin resistance
[85–88]. Activation of JNK in obesity may be a particular
consequence of ER stress since IRE-1 has, apart from en-
doribonuclease activity, also kinase activity that activates
JNK (Fig. 4). The liver and adipose tissue of genetic and
high-fat diet-induced mouse models of obesity demon-
strated increased levels of several ER stress markers as
well as induction of insulin resistance via increased Ser
phosphorylation/decreased Tyr phosporylation IRS-1. It is
of interest that JNK and IKK are also potential links
between ER stress and inﬂammation [89]. Other evidence
for a link between ER stress and insulin resistance comes
from studies using chaperones, such as 4-phenyl butyric
acid (PBA), trimethylamine N-oxide dihydrate (TMAO),
and dimethyl sulfoxide or oxygen regulated protein 150kD
1430 Apoptosis (2009) 14:1424–1434
123(ORP150). These chaperones protect cells from ER stress,
e.g via stabilization of protein conformation, improvement
of ER folding capacity, and therefore enhance the adaptive
capacity of the ER. Introduction of chaperones increased
insulin sensitivity in the liver of obese diabetic mice
[8, 90]. Moreover, an in vitro model of hepatocytes
(HepG2) shows that triglycerides induce the expression
of endogenous ER stress markers, including GRP 78,
IRE-1alpha, XBP-1, p-eIF2alpha, CHOP, and p-JNK. ER
stress, in turn, leads to the suppression of insulin receptor
signalling through increase in serine phosphorylation and
decrease of tyrosine phosphorylation of insulin receptor
substrate-1 (IRS-1), and therefore insulin resistance [91].
More evidence for a link between insulin resistance and ER
stress is shown in a study using a mouse model that is
hypersensitive to insulin (i.e. liver-speciﬁc-PTP1B deﬁ-
cient mice). The livers of these mice are both insulin
sensitive and protected against a high fat diet-induced ER
stress response [92].
Conclusion
Taken together, these data indicate that ER stress plays a
role in diabetes by affecting at least two major events:
b-cell failure and generation of insulin resistance. Although
most of the current understanding of the known mediators
of the ER stress pathway comes from other experimental
systems, it is clear that ER stress-induced apoptosis of b
cells plays a role in the development of diabetes. Data
obtained in liver and adipose tissue suggest that also ER
stress-induced apoptosis in these tissues is important in the
development of diabetes. In contrast to apoptosis of b cells,
which will primarily affect insulin production, ER induced
apoptosis in liver and adipose tissue will rather lead to
increased insulin resistance. More extensive studies with
human adipocytes and hepatocytes are needed to identify
the exact interactions between environmental signals and
ER stress.
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